Marshall Wace’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37.7K | Hold |
14,115
| – | – | ﹤0.01% | 2466 |
|
|
2025
Q1 | $113K | Sell |
14,115
-1
| -0% | -$8 | ﹤0.01% | 2356 |
|
|
2024
Q4 | $136K | Hold |
14,116
| – | – | ﹤0.01% | 2242 |
|
|
2024
Q3 | $263K | Hold |
14,116
| – | – | ﹤0.01% | 2036 |
|
|
2024
Q2 | $234K | Sell |
14,116
-1,759
| -11% | -$29.1K | ﹤0.01% | 2042 |
|
|
2024
Q1 | $274K | Buy |
15,875
+1,759
| +12% | +$30.3K | ﹤0.01% | 1881 |
|
|
2023
Q4 | $221K | Hold |
14,116
| – | – | ﹤0.01% | 1649 |
|
|
2023
Q3 | $698K | Hold |
14,116
| – | – | ﹤0.01% | 1356 |
|
|
2023
Q2 | $1.1M | Hold |
14,116
| – | – | ﹤0.01% | 1341 |
|
|
2023
Q1 | $1.28M | Hold |
14,116
| – | – | ﹤0.01% | 1331 |
|
|
2022
Q4 | $1.67M | Hold |
14,116
| – | – | ﹤0.01% | 1415 |
|
|
2022
Q3 | $2.56M | Hold |
14,116
| – | – | 0.01% | 1466 |
|
|
2022
Q2 | $1.27M | Hold |
14,116
| – | – | ﹤0.01% | 1775 |
|
|
2022
Q1 | $2.19M | Sell |
14,116
-131
| -0.9% | -$20.3K | ﹤0.01% | 1588 |
|
|
2021
Q4 | $4.24M | Buy |
+14,247
| New | +$4.24M | 0.01% | 1289 |
|
|
2021
Q2 | – | Sell |
-6,650
| Closed | -$3.58M | – | 2648 |
|
|
2021
Q1 | $3.58M | Buy |
6,650
+6,292
| +1,758% | +$3.39M | 0.02% | 909 |
|
|
2020
Q4 | $316K | Sell |
358
-694
| -66% | -$613K | ﹤0.01% | 1500 |
|
|
2020
Q3 | $666K | Buy |
+1,052
| New | +$666K | ﹤0.01% | 1122 |
|